Predicate |
Object |
assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_a5ffa3f9d6b87e15e0a1551fb129b531 http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_f41b2f497ce5cdc063d4c73a922f3238 http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_8763cc76ad1cd8ba9d1d09d446caafff http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_9f4b08143bd2040ef9cc750753044ba9 http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_fd76209907eb2db589af21bc88f12a2e http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_efa70e241ba9713f5da68f2bfeea7fbd |
classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-008 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K45-06 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-4704 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-485 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P11-06 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P11-08 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P11-00 |
classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-05 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-11 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-4704 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-135 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-485 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-12 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K45-06 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P11-06 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P11-08 |
filingDate |
2003-06-18-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
grantDate |
2012-01-03-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_1f095a1d0ba834fd60a79a2c1840aa6a http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_29c8a880b420cbf06b9021a245c7c29e http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_d4c3e23a0225c9525e82ddbd4f01ba36 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_f0c0ae7f3a57b0c6e2c333c76bc23d5f http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_b1c6947636ba07f8b034fc257b984f52 |
publicationDate |
2012-01-03-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber |
US-8088362-B2 |
titleOfInvention |
Salmeterol superfine formulation |
abstract |
The present invention relates to a pharmaceutical formulation for use in the administration of a long-acting β 2 -agonist by inhalation. In particular this invention relates to a chemically stable, highly efficient salmeterol HFA solution formulation to be administered by pressurized metered dose inhalers (pMDIs) characterized by a deep lung penetration. The invention also relates to methods for the preparation of said formulation and to its use in respiratory diseases such as asthma and chronic obstructive pulmonary disease (COPD). |
isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-11213485-B2 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-10525006-B2 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2017065518-A1 |
priorityDate |
2002-10-23-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
type |
http://data.epo.org/linked-data/def/patent/Publication |